Search and analyze individual stocks with comprehensive metrics
Kobo Biotech
Fundamental Score
Kobo Biotech Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of KOBO across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Strong Cash Generation (₹124.71 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Suboptimal ROCE (-52.90%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Limited Institutional Interest (FII+DII: 0.66%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Commodity Chemicals sector...
Financial Statements
Comprehensive financial data for Kobo Biotech
About KOBO
Company Details
Market Information
Performance
KOBO Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of KOBO?
KOBO is currently trading at ₹2.38 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of KOBO shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of KOBO and what does it mean?
KOBO has a P/E ratio of N/Ax compared to the industry average of 22.17x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.
How is KOBO performing according to Bull Run's analysis?
KOBO has a Bull Run fundamental score of 20.3/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: N/A%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does KOBO belong to?
KOBO operates in the Chemicals & Petrochemicals industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Kobo Biotech. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for KOBO?
KOBO has an ROE of N/A%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Kobo Biotech generates profits from shareholders' equity. An ROE of N/A% means the company generates ₹N/A profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is KOBO's debt-to-equity ratio and what does it indicate?
KOBO has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk. This means the company has ₹0 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.
What is KOBO's dividend yield and is it a good dividend stock?
KOBO offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has KOBO grown over the past 5 years?
KOBO has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 12.21%, and EPS Growth 12.21%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in KOBO and why does it matter?
Promoters hold 44.95% of KOBO shares, with 0.00% of promoter shares pledged. This promoter holding level suggests balanced ownership between management and public shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.
How does KOBO compare with its industry peers?
KOBO trades at P/E N/Ax vs industry average 22.17x, with ROE of N/A% and ROCE of -52.90%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether KOBO is outperforming its competitive set in profitability, growth, and valuation metrics.
What is KOBO's market capitalization and what category does it fall into?
KOBO has a market capitalization of ₹6 crores, making it a Small-cap stock. Small-cap stocks offer high growth potential but with higher volatility and risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for KOBO?
Key ratios for KOBO: ROE N/A% (Needs improvement), ROCE -52.90%, P/E N/Ax, Debt-to-Equity N/A, Interest Coverage N/Ax. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is KOBO stock and what is its beta?
KOBO has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for KOBO?
KOBO has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹2.38, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in KOBO?
Key risks for KOBO include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: N/A), and operational challenges. The stock has a Fundamental Score of 20.3/100, indicating higher risk requiring thorough due diligence. Sector-specific risks in Chemicals & Petrochemicals include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is KOBO's operating profit margin and how has it trended?
KOBO has a 5-year average Operating Profit Margin (OPM) of N/A%, which suggests room for improvement in operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.
How is KOBO's quarterly performance in terms of sales and profit growth?
KOBO's recent quarterly performance shows YoY Sales Growth of N/A% and YoY Profit Growth of -8.13%. Growth rates indicate the current business trajectory and market demand. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in KOBO?
KOBO has FII holding of 0.00% and DII holding of 0.66%, totaling 0.66% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.